Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. 1998

L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
University of Southern California School of Medicine, Los Angeles 90033, USA.

BACKGROUND Proton-pump inhibitor therapy may cause false-negative results on Helicobacter pylori diagnostic testing. OBJECTIVE To determine the frequency and duration of conversion of urea breath test results from positive to negative in patients given a proton-pump inhibitor. METHODS Two urban university gastroenterology clinics. METHODS Patients infected with H. pylori who had positive results on urea breath tests. METHODS Lansoprazole, 30 mg/d for 28 days. METHODS The urea breath test was repeated at 28 days. If the results were negative, testing was repeated 3, 7, 14, and 28 days after completion of therapy until the results reverted to positive. RESULTS 31 (33%) of 93 patients in whom H. pylori was not eradicated had a negative breath test result while receiving lansoprazole. The proportions of patients whose breath test results were positive after completion of lansoprazole therapy were 91% (95% CI, 83% to 96%) at 3 days, 97% (CI, 90% to 99%) at 7 days, and 100% (CI, 96% to 100%) at 14 days. CONCLUSIONS Patients should not receive proton-pump inhibitors for 2 weeks before receiving the urea breath test for H. pylori infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009853 Omeprazole A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. H 168-68,Omeprazole Magnesium,Omeprazole Sodium,Prilosec,H 168 68,H 16868,Magnesium, Omeprazole,Sodium, Omeprazole
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001944 Breath Tests Any tests done on exhaled air. Breathalyzer Tests,Breath Test,Breathalyzer Test,Test, Breath,Test, Breathalyzer,Tests, Breath,Tests, Breathalyzer
D003951 Diagnostic Errors Incorrect or incomplete diagnoses following clinical or technical diagnostic procedures. Diagnostic Blind Spots,Errors, Diagnostic,Misdiagnosis,Blind Spot, Diagnostic,Blind Spots, Diagnostic,Diagnostic Blind Spot,Diagnostic Error,Error, Diagnostic,Misdiagnoses
D005188 False Negative Reactions Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Negative Reaction,Reaction, False Negative,Reactions, False Negative
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer

Related Publications

L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
April 2018, European journal of internal medicine,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
January 1992, Scandinavian journal of gastroenterology,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
February 2002, Nihon rinsho. Japanese journal of clinical medicine,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
January 2004, Gut,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
July 1997, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
September 2006, Basic & clinical pharmacology & toxicology,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
January 2015, Clinical interventions in aging,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
September 2012, Journal of clinical biochemistry and nutrition,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
March 2003, Methods and findings in experimental and clinical pharmacology,
L Laine, and R Estrada, and M Trujillo, and K Knigge, and M B Fennerty
March 2015, Alimentary pharmacology & therapeutics,
Copied contents to your clipboard!